Pharmena S.A. (PHR) Stock Statistics & Valuation Metrics

Pharmena S.A. has a market cap or net worth of zł38.76M. The enterprise value is ―.

Pharmena S.A. has 11,137,758 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharmena S.A.’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -13.21%.

The current PE Ratio of Pharmena S.A. is ―. Pharmena S.A.’s PEG ratio is 0.32.

In the last 12 months, Pharmena S.A. had revenue of 268.00K and earned -1.26M in profits. Earnings per share was -0.11.

In the last 12 months, operating cash flow was -1.92M and capital expenditures -9.26M, giving a free cash flow of -11.19M billion.

Pharmena S.A. pays an annual dividend of zł0.85, resulting in a dividend yield of 23.94%

Pharmena S.A. upcoming earnings date is ―, ―.

Pharmena S.A. as a current ratio of 12.98, with Debt / Equity ratio of 1.80%

In the past 12 months, Pharmena S.A. has paid -1.29M in taxes.

Pharmena S.A. EV to EBITDA ratio is -12.17, with an EV/FCF ratio of -15.18.

Pharmena S.A. has zł209.00K in cash and marketable securities with zł202.00K in debt, giving a net cash position of zł7.00K billion.

Gross margin is -32.96%, with operating margin of -1267.54%, and net profit margin of -470.90%.

The average price target for Pharmena S.A. is ―, which is 11.43% higher than the current price. The consensus rating is ―